• Press Releases

SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

Read Press Release from
October 6, 2020

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile f...

Read Press Release from
July 29, 2020

SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheuma...

Read Press Release from
May 6, 2020

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

Read Press Release from
November 14, 2019

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patie...

Read Press Release from
October 29, 2019

SetPoint Medical Appoints Anna Gawlicka as Vice President of Clinical Affairs

Read Press Release from
September 10, 2019

SetPoint Medical Reports Positive Results from its U.S. Pilot Study in Rheumatoid Arthritis

Read Press Release from
June 17, 2019

SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European ...

Read Press Release from
June 3, 2019

SetPoint Medical to Present at Guggenheim 2019 MedTech Disruptors Summit

Read Press Release from
May 22, 2019

SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Dise...

Read Press Release from
May 20, 2019

SetPoint Medical to Present at Bank of America Merrill Lynch Health Care Conference 2019

Read Press Release from
April 30, 2019

SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for T...

Read Press Release from
October 23, 2018